| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.9 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.9 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |